Madrazo, M.; López-Cruz, I.; Piles, L.; Civera, M.; Eiros, J.M.; Alberola, J.; Artero, A.
Clinical Impact of Empiric Ceftriaxone for Hospitalized Patients with Community-Onset Healthcare-Associated UTIs. J. Clin. Med. 2025, 14, 8761.
https://doi.org/10.3390/jcm14248761
AMA Style
Madrazo M, López-Cruz I, Piles L, Civera M, Eiros JM, Alberola J, Artero A.
Clinical Impact of Empiric Ceftriaxone for Hospitalized Patients with Community-Onset Healthcare-Associated UTIs. Journal of Clinical Medicine. 2025; 14(24):8761.
https://doi.org/10.3390/jcm14248761
Chicago/Turabian Style
Madrazo, Manuel, Ian López-Cruz, Laura Piles, MarÃa Civera, José MarÃa Eiros, Juan Alberola, and Arturo Artero.
2025. "Clinical Impact of Empiric Ceftriaxone for Hospitalized Patients with Community-Onset Healthcare-Associated UTIs" Journal of Clinical Medicine 14, no. 24: 8761.
https://doi.org/10.3390/jcm14248761
APA Style
Madrazo, M., López-Cruz, I., Piles, L., Civera, M., Eiros, J. M., Alberola, J., & Artero, A.
(2025). Clinical Impact of Empiric Ceftriaxone for Hospitalized Patients with Community-Onset Healthcare-Associated UTIs. Journal of Clinical Medicine, 14(24), 8761.
https://doi.org/10.3390/jcm14248761